| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4467 | 2020 |
| Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetes care 41 (12), 2669-2701, 2018 | 4190 | 2018 |
| Dapagliflozin in patients with chronic kidney disease HJL Heerspink, BV Stefánsson, R Correa-Rotter, GM Chertow, T Greene, ... New England Journal of Medicine 383 (15), 1436-1446, 2020 | 3664 | 2020 |
| 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study … JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ... Diabetes care 43 (2), 487-493, 2020 | 1814 | 2020 |
| New creatinine-and cystatin C–based equations to estimate GFR without race LA Inker, ND Eneanya, J Coresh, H Tighiouart, D Wang, Y Sang, ... New England Journal of Medicine 385 (19), 1737-1749, 2021 | 1716 | 2021 |
| Cardiorenal end points in a trial of aliskiren for type 2 diabetes HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ... New England Journal of Medicine 367 (23), 2204-2213, 2012 | 1635 | 2012 |
| Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, P Rossing, P Kolkhof, ... New England journal of medicine 383 (23), 2219-2229, 2020 | 1617 | 2020 |
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis CS Fox, K Matsushita, M Woodward, HJG Bilo, J Chalmers, ... The Lancet 380 (9854), 1662-1673, 2012 | 1267 | 2012 |
| Cardiovascular events with finerenone in kidney disease and type 2 diabetes B Pitt, G Filippatos, R Agarwal, SD Anker, GL Bakris, P Rossing, A Joseph, ... New England Journal of Medicine 385 (24), 2252-2263, 2021 | 881 | 2021 |
| Diabetic kidney disease MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ... Nature reviews Disease primers 1 (1), 1-20, 2015 | 873 | 2015 |
| Diabetes and hypertension: a position statement by the American Diabetes Association IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, P Muntner, ... Diabetes care 40 (9), 1273-1284, 2017 | 824 | 2017 |
| Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease … BC Astor, K Matsushita, RT Gansevoort, M Van Der Velde, M Woodward, ... Kidney international 79 (12), 1331-1340, 2011 | 805 | 2011 |
| Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetes care 45 (11), 2753-2786, 2022 | 725 | 2022 |
| Age and association of kidney measures with mortality and end-stage renal disease SI Hallan, K Matsushita, Y Sang, BK Mahmoodi, C Black, A Ishani, ... Jama 308 (22), 2349-2360, 2012 | 705 | 2012 |
| Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial GL Bakris, B Pitt, MR Weir, MW Freeman, MR Mayo, D Garza, Y Stasiv, ... Jama 314 (2), 151-161, 2015 | 626* | 2015 |
| A catalog of genetic loci associated with kidney function from analyses of a million individuals M Wuttke, Y Li, M Li, KB Sieber, MF Feitosa, M Gorski, A Tin, L Wang, ... Nature genetics 51 (6), 957-972, 2019 | 624 | 2019 |
| Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial GL Bakris, R Agarwal, JC Chan, ME Cooper, RT Gansevoort, H Haller, ... Jama 314 (9), 884-894, 2015 | 606 | 2015 |
| Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ... Diabetologia 59 (11), 2298-2307, 2016 | 586 | 2016 |
| KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease IH de Boer, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 98 (4), S1-S115, 2020 | 581 | 2020 |
| Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study P Rossing, P Hougaard, K Borch-Johnsen, HH Parving Bmj 313 (7060), 779-784, 1996 | 576 | 1996 |
